621 results on '"Tie, Jeanne"'
Search Results
2. Trastuzumab deruxtecan in patients with HER2-positive advanced colorectal cancer (DESTINY-CRC02): primary results from a multicentre, randomised, phase 2 trial
3. BRAFV600E-Mutant Metastatic Colorectal Cancer: Current Evidence, Future Directions, and Research Priorities
4. The prognostic impact of peritoneal tumour DNA in gastrointestinal and gynaecological malignancies: a systematic review
5. Standardizing data collection in adjuvant colon cancer trials: A consensus project from the IDEA and ACCENT international consortia and national experts
6. Re: Molecular testing to deliver personalised chemotherapy recommendations
7. Health economic evidence for adjuvant chemotherapy in stage II and III colon cancer: a systematic review
8. Adjuvant Chemotherapy for Older Patients With Stage III Colorectal Cancer: A Real-World Analysis of Treatment Recommendations, Treatment Administered and Impact on Cancer Recurrence
9. Peritoneal Tumor DNA as a Prognostic Biomarker in Gastric Cancer: A Systematic Review and Meta-Analysis
10. Seek and ye shall find : Hodgkin's lymphoma presenting as paraneoplastic cerebellar degeneration
11. Initial Assessment of Resectability of Colorectal Cancer Liver Metastases Versus Clinical Outcome
12. A tailored approach to horizon scanning for cancer medicines
13. Clinical application of circulating tumour DNA in colorectal cancer
14. The Impact of Neoadjuvant Chemotherapy on the Surgical Management of Colorectal Peritoneal Metastases: A Systematic Review and Meta-Analysis
15. Blood Test for Multicancer Detection in Symptomatic Individuals
16. Real world impact of pembrolizumab availability for deficient mismatch repair metastatic colorectal cancer.
17. Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: Overall survival and updated 5-year results from the randomized DYNAMIC trial.
18. A systematic review and meta-analysis of toxicity and treatment outcomes with pharmacogenetic-guided dosing compared to standard of care BSA-based fluoropyrimidine dosing
19. The impact of molecular and mismatch repair status on the survival outcomes of surgically treated patients with colorectal peritoneal metastases
20. A longitudinal cohort study of watch and wait in complete clinical responders after chemo-radiotherapy for localised rectal cancer: study protocol
21. Biomarkers in Locally Advanced Rectal Cancer: A Review
22. Liquid biopsies for residual disease and recurrence
23. Treatment and Outcomes of Oligometastatic Colorectal Cancer Limited to Lymph Node Metastases
24. Assessing aneuploidy with repetitive element sequencing
25. Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: A Systematic Review and Metaanalysis of Oncological and Operative Outcomes
26. Detection of low-frequency DNA variants by targeted sequencing of the Watson and Crick strands
27. Real-World Treatment and Outcomes of Metastatic Colorectal Cancer Patients With a Poor or Very Poor Performance Status
28. Circulating Tumour DNA as a Potential Cost-Effective Biomarker to Reduce Adjuvant Chemotherapy Overtreatment in Stage II Colorectal Cancer
29. Cardiovascular disease and stroke following cancer and cancer treatment in older adults.
30. BRAFV600E Mutations Arising from a Left-Side Primary in Metastatic Colorectal Cancer: Are They a Distinct Subset?
31. Circulating tumor DNA analysis informing adjuvant chemotherapy in locally advanced rectal cancer: The randomized AGITG DYNAMIC-Rectal study.
32. A Practical Approach to Interpreting Circulating Tumor DNA in the Management of Gastrointestinal Cancers
33. Girdin (GIV) Expression as a Prognostic Marker of Recurrence in Mismatch Repair–Proficient Stage II Colon Cancer
34. Circulating Tumour DNA and Colorectal Cancer: the Next Revolutionary Biomarker?
35. Landscape of KRASG12C, Associated Genomic Alterations, and Interrelation With Immuno-Oncology Biomarkers in KRAS-Mutated Cancers
36. Simulating Progression-Free and Overall Survival for First-Line Doublet Chemotherapy With or Without Bevacizumab in Metastatic Colorectal Cancer Patients Based on Real-World Registry Data
37. Outcomes Following Cytoreduction and HIPEC for Pseudomyxoma Peritonei: 10-Year Experience
38. Management of Distant Metastasis in Differentiated Thyroid Cancer
39. Reply to: Does Total Neoadjuvant Treatment Improve Overall Survival in Rectal Cancer? No, It Does Not
40. Circulating Tumour DNA Guided Adjuvant Chemotherapy Decision Making in Stage II Colon Cancer—A Clinical Vignette Study
41. Patient and health care professional acceptability of pharmacogenetic screening for DPYD and UGT1A1: a cross sectional survey
42. Figure S7 from The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer
43. The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer
44. Detection and localization of surgically resectable cancers with a multi-analyte blood test
45. Glucagonoma Masquerading as a Mucinous Cancer of the Ovary: Lessons from Cell Biology
46. Tailoring immunotherapy with liquid biopsy
47. Evaluation of cytoreductive surgery and HIPEC for peritoneal surface malignancies: analysis of 384 consecutive cases
48. Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers
49. Triaging suspected cancer with a multi-cancer early detection blood test
50. Pharmacogenetics testing (DPYD and UGT1A1) for fluoropyrimidine and irinotecan in routine clinical care: Perspectives of medical oncologists and oncology pharmacists.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.